2025-10-09 - Analysis Report
Okay, here's an analysis of Honeywell International (HON) based on the provided data.

## Honeywell International (HON) Analysis

**Company Overview:** Honeywell International Inc. is a diversified technology and manufacturing company that serves customers worldwide.

### 1. Performance vs. S&P 500 (VOO)

*   **HON Cumulative Return:** 15.42%
*   **VOO Cumulative Return:** 99.62%
*   **Absolute Divergence:** -83.5%
*   **Relative Divergence:** 0.0 (meaning the current divergence is at the very low end of its historical range).

**Analysis:** HON has significantly underperformed the S&P 500 (VOO) based on the provided cumulative returns. The large negative divergence and relative divergence of 0.0 indicate substantial underperformance compared to its historical relationship with the S&P 500.

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B) |
| :----------- | :----- | :----- | :------ | :----- | :----- |
| 2015-2017  | 33.0%  | 67.3%  | 5.0%    | -0.0   | 93.3   |
| 2016-2018  | 15.0%  | 71.0%  | 0.0%    | 0.1    | 83.9   |
| 2017-2019  | 29.0%  | 71.1%  | 7.0%    | 1.0    | 112.4  |
| 2018-2020  | 6.0%   | 79.4%  | -18.0%  | 1.0    | 135.0  |
| 2019-2021  | 19.0%  | 79.4%  | -28.0%  | 1.2    | 132.4  |
| 2020-2022  | 9.0%   | 79.4%  | 10.0%   | 1.4    | 136.1  |
| 2021-2023  | -9.0%  | 77.9%  | -10.0%  | 1.2    | 133.1  |
| 2022-2024  | -2.0%  | 79.7%  | -22.0%  | 1.2    | 143.4  |
| 2023-2025  | -16.0% | 79.7%  | -80.0%  | 2.0    | 133.2  |

*   **CAGR:** Varies significantly across different periods, with negative CAGRs in recent years (2021-2025).
*   **MDD:** High Maximum Drawdowns (MDD) indicate substantial risk and volatility.
*   **Alpha:**  Alpha is largely negative in recent years, indicating underperformance relative to the market risk-adjusted return.  The -80% alpha for 2023-2025 is particularly concerning.
*   **Beta:** Beta values generally near or above 1.0 suggest that HON's price tends to move more than the overall market.  The beta of 2.0 for 2023-2025 suggests very high market sensitivity.
*   **Cap(B):** Market Cap in Billions.

### 2. Recent Stock Price Action

*   **Current Price:** \$209.85
*   **Previous Close:** \$208.98
*   **Change:** \$0.42
*   **5-day Moving Average:** \$209.58
*   **20-day Moving Average:** \$210.05
*   **60-day Moving Average:** \$217.63

**Analysis:** The stock price has seen a slight increase recently. The 5-day moving average is below the 20-day moving average, which is below the 60-day moving average. This *could* indicate a short-term upward trend, but the price is still below the longer-term 60-day average, suggesting that the overall trend may still be downward or sideways.  The current price change of $0.42 isn't large enough on its own to indicate a significant volatility event.

### 3. Technical Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 48.23 (Neutral)
*   **PPO:** 0.19 (Potentially slightly bullish)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash
*   **Delta_Previous_Relative_Divergence (20-day):** -1.1 (Short-term Decline)
*   **Expected Return:** -2817.1% (Significant underperformance vs. S&P 500)

**Analysis:**

*   **MRI:** Despite the negative performance, the MRI suggests a high investment recommendation.  This might be due to the model's assessment of broader market conditions or factors not fully captured in the provided data.
*   **RSI:** An RSI of 48.23 is neutral, indicating neither overbought nor oversold conditions.
*   **PPO:** The PPO being slightly positive *could* suggest emerging bullish momentum, but the magnitude is low.
*   **Delta_Previous_Relative_Divergence:** The negative change in relative divergence confirms the short-term underperformance trend.
*   **Expected Return:**  The extremely negative expected return is highly concerning and suggests the model predicts significant underperformance compared to the S&P 500 over a 2+ year investment horizon.

### 4. Recent News & Significant Events

*   **Partnership with LS Electric:** This partnership to advance data center power management tools and battery energy storage systems is a positive development, indicating growth opportunities in relevant sectors.
*   **Solstice Advanced Materials Investor Day:** This event could provide insights into the performance and future plans of this business segment.
*   **Jim Cramer on Honeywell's Breakup:**  Discussion of a potential breakup suggests strategic considerations and potential value unlocking.
*   **Aircraft Lighting Market Report:** Honeywell's presence in the aircraft lighting market indicates diversification but also exposure to the aerospace industry.
*   **Jefferies & Co Price Target Adjustment:** A lowered price target from $240 to $230 with a "Hold" rating suggests a cautious outlook from this analyst firm.

### 4-2. Analyst Opinions

*   **Consensus:** Buy (Mean: 1.96)
*   **Target Price:** \$251.78 (Mean)
*   **Target Price Range:** \$210.00 - \$290.00

**Analysis:** The analyst consensus is generally positive ("Buy"), and the mean target price is significantly higher than the current price. However, the range of target prices is wide, suggesting uncertainty. The recent price target adjustment by Jefferies & Co is a negative signal.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출      |
| :--------- | :--- | :-------- |
| 2025-07-24 | 2.46 | 10.35 B\$ |
| 2025-04-29 | 2.24 | 9.82 B\$  |
| 2024-10-24 | 2.17 | 9.73 B\$  |
| 2024-07-25 | 2.37 | 9.58 B\$  |
| 2025-07-24 | 2.37 | 9.58 B\$  |

**Analysis:**

*   Revenue has generally been increasing in recent quarters, but inconsistent.
*   EPS has fluctuated, with a recent peak in 2025-07-24.

### 6. Financial Information

| Quarter    | Revenue    | Profit Margin |
| :--------- | :--------- | :-------------- |
| 2025-06-30 | \$10.35B  | 38.86%          |
| 2025-03-31 | \$9.82B   | 38.54%          |
| 2024-12-31 | \$10.09B  | 36.38%          |
| 2024-09-30 | \$9.73B   | 38.54%          |
| 2024-06-30 | \$9.58B   | 38.85%          |

| Quarter    | Equity     | ROE     |
| :--------- | :--------- | :------ |
| 2025-06-30 | \$16.09B  | 9.75%   |
| 2025-03-31 | \$17.46B  | 8.30%   |
| 2024-12-31 | \$18.62B  | 6.90%   |
| 2024-09-30 | \$17.41B  | 8.12%   |
| 2024-06-30 | \$16.95B  | 9.11%   |

**Analysis:**

*   **Revenue:**  Revenue shows a generally positive trend, but with some fluctuations.
*   **Profit Margin:** Profit margins are relatively stable, indicating consistent profitability.
*   **Equity:** Equity has decreased over the period.
*   **ROE:** Return on Equity (ROE) has fluctuated, but decreased overall.

### 7. Overall Summary

Honeywell International (HON) presents a mixed picture:

*   **Negative Signals:** Significant underperformance compared to the S&P 500, negative alpha in recent years, and a very concerning negative expected return.  Recent price action is below the 60-day moving average, suggesting weakness. The negative divergence and decline in relative divergence indicate short-term underperformance. Equity is decreasing.
*   **Positive Signals:** Recent earnings and revenue growth. The MRI suggests high investment. A slightly positive PPO could indicate emerging bullish momentum.
*   **Mixed Signals:** Analyst consensus is "Buy," but a recent price target reduction provides a note of caution. Partnerships and investor events could be positive catalysts.

**Conclusion:**

Based on this data, caution is warranted. The underperformance relative to the S&P 500 and the negative expected return are significant red flags. While recent earnings and analyst ratings are positive, they are not enough to outweigh the negative signals. The high investment recommendation from the MRI should be viewed with skepticism in light of the other data. A potential investor should investigate further to understand the reasons for the underperformance and negative expected return.
